Andrea Baragetti Redefines the Dialogue Between Heart and Kidney at EAS Milan
Andrea Baragetti, Associate Professor of Pharmacology at University of Milan, posted on LinkedIn:
”On the frontline of cardiovascular innovation
In Milan, at the European Atherosclerosis Society Advanced Course on Non-Classical Risk Factors, I had the privilege to stand among brilliant scientists and clinicians united by a single mission – to challenge what’s known and redefine the limits of cardiovascular and metabolic medicine.
Gratitude to the organizers and the European Atherosclerosis Society (EAS) for the opportunity to contribute with a talk on upfront therapeutic perspectives on cardio-renal syndrome – a field where the heart and kidney engage in a silent but relentless dialogue, and where every new insight can shift the balance between failure and recovery.
Science is a weapon, innovation is a creed.”
Keep up with Hemostasis Today.
-
Feb 3, 2026, 17:39Breaking News from WHO Executive Board Session in Geneva – WFH
-
Feb 3, 2026, 17:26Francesco Lo Monaco: When Calcium Goes to the Wrong Place – Vitamin K and the Mechanisms of Vascular Calcification
-
Feb 3, 2026, 17:18Khalid Ahmed: The HALO Study to Understand Quality of Life After Childhood Hematological Disorders
-
Feb 3, 2026, 17:09Mahesan Subramaniam: The Impact of Chronic Financial Stress and Instability on Cardiovascular Health
-
Feb 3, 2026, 17:01Sunisha A: Deep Vein Thrombosis – A Silent but Serious Threat
-
Feb 3, 2026, 16:56Vicklen Pesiwarissa: Upper Extremity Deep Vein Thrombosis as a Cause of Pulmonary Embolism
-
Feb 3, 2026, 16:52Hope, Independence and Dignity for People with Bleeding Disorders Through the WFH Humanitarian Aid Program
-
Feb 3, 2026, 16:34Join the EHC Round Table on Extremely Rare Bleeding Disorders
-
Feb 3, 2026, 16:30Robert Weber: The ‘Bone Marrow Hack’ – Releasing Stem Cells Using Light, Not Needles